Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic - 41 PEPFAR-Supported Countries, 2020
- PMID: 35324881
- PMCID: PMC8956337
- DOI: 10.15585/mmwr.mm7112a2
Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic - 41 PEPFAR-Supported Countries, 2020
Abstract
The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) supports country programs in identifying persons living with HIV infection (PLHIV), providing life-saving treatment, and reducing the spread of HIV in countries around the world (1,2). CDC used Monitoring, Evaluation, and Reporting (MER) data* to assess the extent to which COVID-19 mitigation strategies affected HIV service delivery across the HIV care continuum† globally during the first year of the COVID-19 pandemic. Indicators included the number of reported HIV-positive test results, the number of PLHIV who were receiving antiretroviral therapy (ART), and the rates of HIV viral load suppression. Percent change in performance was assessed between countries during the first 3 months of 2020, before COVID-19 mitigation efforts began (January-March 2020), and the last 3 months of the calendar year (October-December 2020). Data were reviewed for all 41 countries to assess total and country-level percent change for each indicator. Then, qualitative data were reviewed among countries in the upper quartile to assess specific strategies that contributed to programmatic gains. Overall, positive percent change was observed in PEPFAR-supported countries in HIV treatment (5%) and viral load suppression (2%) during 2020. Countries reporting the highest gains across the HIV care continuum during 2020 attributed successes to reducing or streamlining facility attendance through strategies such as enhancing index testing (offering of testing to the biologic children and partners of PLHIV)§ and community- and home-based testing; treatment delivery approaches; and improvements in data use through monitoring activities, systems, and data quality checks. Countries that reported program improvements during the first year of the COVID-19 pandemic offer important information about how lifesaving HIV treatment might be provided during a global public health crisis.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Figures

Similar articles
-
Protecting the gains: analysis of HIV treatment and service delivery programme data and interventions implemented in 19 African countries during COVID-19.J Int AIDS Soc. 2022 Nov;25(11):e26033. doi: 10.1002/jia2.26033. J Int AIDS Soc. 2022. PMID: 36419346 Free PMC article.
-
Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic - Nine States, Nigeria, March 31, 2019-September 30, 2020.MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):421-426. doi: 10.15585/mmwr.mm7012a3. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33764965 Free PMC article.
-
Pediatric HIV Case Identification Across 22 PEPFAR-Supported Countries During the COVID-19 Pandemic, October 2019-September 2020.MMWR Morb Mortal Wkly Rep. 2022 Jul 15;71(28):894-898. doi: 10.15585/mmwr.mm7128a2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35834422 Free PMC article.
-
Addressing advanced HIV disease and mortality in global HIV programming.AIDS Res Ther. 2020 Jul 10;17(1):40. doi: 10.1186/s12981-020-00296-x. AIDS Res Ther. 2020. PMID: 32650797 Free PMC article. Review.
-
The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic.J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S51-6. doi: 10.1097/QAI.0b013e31825ca721. J Acquir Immune Defic Syndr. 2012. PMID: 22797740 Review.
Cited by
-
HIV Testing Disruptions and Service Adaptations During the COVID-19 Pandemic: A Systematic Literature Review.AIDS Behav. 2024 Jan;28(1):186-200. doi: 10.1007/s10461-023-04139-4. Epub 2023 Aug 7. AIDS Behav. 2024. PMID: 37548796 Free PMC article.
-
Vital Signs: Progress Toward Eliminating HIV as a Global Public Health Threat Through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President's Emergency Plan for AIDS Relief - Worldwide, 2004-2022.MMWR Morb Mortal Wkly Rep. 2023 Mar 24;72(12):317-324. doi: 10.15585/mmwr.mm7212e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36952290 Free PMC article.
-
Pediatric and adolescent HIV viral load coverage and suppression rates in the context of the COVID-19 pandemic in 12 PEPFAR-supported sub-Saharan African countries in 2019 and 2020.PLOS Glob Public Health. 2024 Aug 1;4(8):e0003513. doi: 10.1371/journal.pgph.0003513. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39088480 Free PMC article.
-
Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021.Lancet HIV. 2024 Dec;11(12):e807-e822. doi: 10.1016/S2352-3018(24)00212-1. Epub 2024 Nov 25. Lancet HIV. 2024. PMID: 39608393 Free PMC article.
-
Partnerships, Collaborations, and Investments Integral to CDC's International Response to COVID-19.Emerg Infect Dis. 2022 Dec;28(13):S1-S3. doi: 10.3201/eid2813.221751. Emerg Infect Dis. 2022. PMID: 36496350 Free PMC article. Review. No abstract available.
References
-
- Joint United Nations Programme on HIV. AIDS info database. Geneva, Switzerland: Joint United Nations Programme on HIV; 2020. https://aidsinfo.unaids.org/
-
- The United States President’s Emergency Plan for AIDS Relief. Annual Report to Congress, 2021. Washington, DC: The United States President’s Emergency Plan for AIDS Relief; 2021. https://www.state.gov/wp-content/uploads/2021/02/PEPFAR2021AnnualReportt...
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous